2m 2m 2m 2m 2m 2m 2m
GENELUX (GNLX)
NASDAQ
$1.93-$0.02 (-1.28%)
Price as of Nov 11, 2026 7:56 PM EST- $88.2MMarket Cap
- -67.39%1-Year Change
- BiotechnologyIndustry
GENELUX (GNLX)
$1.93-$0.02 (-1.28%)
GNLX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.95 | ||
Change | -$0.12 (-5.80%) | ||
Open | $2.01 | ||
High | $2.10 | ||
Low | $1.92 | ||
Previous Close | $2.07 | ||
Volume | 93,184 | ||
30-Day Average Volume | 429,868 | ||
1-Week Change | 1.56% | ||
1-Month Change | -23.83% | ||
1-Year Change | -67.39% | ||
3-Year Change | -86.13% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 45.2M | ||
Total Assets | $26.2M | ||
Market Cap | $88.2M | ||
Enterprise Value | $79.0M | ||
Period: QTR TTM FY | |||
Revenue | $3,000.00 | ||
Net Income | -$9.5M | ||
Free Cash Flow | -$8.0M | ||
EBIT | -$9.5M | ||
EBITDA | -$9.5M | ||
Net Working Capital | $11.1M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | 26,348 | ||
P/B | 5 | ||
P/E | -9 | ||
PEG | 2 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue